Photronics, Inc. — FY2022 Form 10-K
Business context and reporting period. Photronics manufactures photomasks used in semiconductor integrated-circuit (IC) and flat-panel-display (FPD) production. This annual report covers the fiscal year ended October 31, 2022; Q4 refers to the three months ended that date. The company operates 11 facilities and earns most of its revenue outside the United States.
Financial performance and position
| Metric | FY2022 | FY2021 |
|---|---|---|
| Revenue | $824.5 million | $663.8 million |
| Gross profit / margin | $294.2 million / 35.7% | $167.0 million / 25.2% |
| Operating income / margin | $211.9 million / 25.7% | $94.6 million / 14.2% |
| Net income attributable to Photronics shareholders | $118.8 million; diluted EPS $1.94 | $55.4 million; diluted EPS $0.89 |
| Operating cash flow | $275.2 million | $150.8 million |
| Free cash flow (non-GAAP) | $166.5 million | $47.4 million |
| Cash and cash equivalents | $319.7 million | $276.7 million |
| Total debt | $42.3 million | $111.7 million |
FY2022 capital expenditures were $112.3 million. Net Cash, a company-defined non-GAAP measure including short-term investments and debt, was $316.2 million versus $165.0 million. About $299.7 million of cash was held by foreign subsidiaries. Current assets were $644.7 million and current liabilities $193.8 million at year-end.
Q4 revenue was $210.3 million, down 4.4% sequentially and up 16.0% year over year. Q4 gross margin was 38.2%, versus 38.1% in Q3 FY2022 and 28.7% in Q4 FY2021. Q4 net income attributable to Photronics shareholders was 17.6% of revenue; the filing’s presented Q4 table does not provide a clear dollar value.
Material changes versus prior year
- Revenue increased 24.2%, led by IC revenue growth of 28.9%; FPD revenue increased 13.7%. Mainstream IC revenue grew 33.8%, while high-end IC revenue grew 19.9%.
- Gross margin expanded 10.5 percentage points. Management attributed the improvement mainly to higher revenue and lower equipment and overhead costs as a share of revenue.
- Operating cash flow rose $124.4 million, primarily reflecting higher earnings and favorable working-capital changes. Free cash flow increased $119.0 million.
- Debt fell by $69.4 million, including repayment of the Hefei equipment loan. The company reported no borrowings under its U.S. corporate credit agreement.
- Foreign-currency transaction impacts contributed $27.3 million of non-operating income, compared with $8.0 million in FY2021. In contrast, foreign-currency translation reduced net assets by $151.2 million and contributed to a $150.8 million comprehensive loss component.
Outlook, risks and unusual items
- Management expects approximately $130 million of capital-expenditure payments in FY2023, directed toward high-end and mainstream manufacturing capacity and efficiency. It stated that liquidity should be sufficient for the next 12 months and the foreseeable future. The filing directs readers to the earnings-call materials for business guidance; specific earnings guidance is not provided in the filing text.
- Capital commitments were substantial: approximately $147.8 million for capital equipment, with $153.1 million of total committed and recognized capital obligations cited in the liquidity discussion. Management estimated $90.0 million would be funded over the next 12 months.
- The company operates in a cyclical, high-fixed-cost industry, with demand tied to customer design activity. Key exposures include customer concentration (the five largest customers generated 45% of revenue), competition and pricing pressure, equipment and raw-material supply constraints, and technology shifts that could reduce photomask demand.
- International operations create foreign-exchange, geopolitical, trade-control, regulatory, and cash-repatriation risks. A 10% adverse currency move was estimated to cause a $34.7 million net unrealized pretax loss at year-end.
- The U.S. credit agreement had a $50 million borrowing limit, expandable to $100 million, and was due to expire in September 2023. It includes financial covenants and restrictions on dividends and share repurchases. Management reported covenant compliance at year-end.
- A noncontrolling partner in the China joint venture has certain put rights; it had not indicated an intention to exercise them. Ordinary-course claims were not expected by management to have a material financial effect.
- The auditor gave an unqualified opinion on the financial statements and internal controls. The critical audit matter concerned management’s estimates for revenue recognized over time on in-process orders; associated revenue and contract assets were $15.8 million at year-end.
Important facts for investors to verify
- Whether FY2023 demand, especially for high-end IC and FPD masks, supports the planned capital spending and utilization.
- How the September 2023 credit-agreement expiration was addressed, including any renewal, refinancing, or covenant changes after the filing date.
- The timing and funding of equipment commitments, and whether the $130 million capex outlook remains current.
- Exposure to the largest customers and the related-party customer relationship; one customer generated $119.0 million of FY2022 revenue.
- Foreign-exchange sensitivity, the effects of currency translation on equity, and access to cash held outside the United States.
- Potential impact of China-related geopolitical or export restrictions and the joint-venture partner’s put rights.